title: Heterogeneous blood pressure response to furosemide and captopril in primary aldosteronism.
abstract: The hypertension associated with primary aldosteronism (PA) is often regarded as volume dependent/salt-sensitive. However, not all patients sustain an increase in blood pressure upon sodium loading. In order to examine the sodium sensitivity in PA, 21 patients with aldosteronoma were tested for acute hypotensive response to intravenous furosemide and oral captopril. Ten patients having a decrease in mean blood pressure (MBP) exceeding 5% at the second hour after a 20 mg furosemide injection were defined as diuretic-responders (DR), while the remainder were defined as diuretic-non-responders (DN). The DR group had a higher baseline MBP (135 +/- 6 [mean +/- SE] vs 121 +/- 4 mmHg, p < 0.05) and serum sodium concentration (145.7 +/- 1.4 vs 143.0 +/- 0.7 mmol/L, p < 0.05) than the DN group. The extent of natriuresis induced by furosemide was not different between the two subgroups. Following 100 mg of captopril administered orally, the DR group had a smaller change in MBP (%) than the DN group (3.08 +/- 5.14 vs -7.78 +/- 3.37, p < 0.05). According to the different BP responses to furosemide and captopril, we conclude that PA patients may be further divided into DR and DN. The DR group had a good response to diuretics whereas the DN group responded better to converting enzyme inhibitors. This classification of PA in terms of blood pressure response to furosemide may have therapeutic implications.
authors.affiliation: Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, R.O.C.
authors.forename: B S
authors.initials: BS
authors.lastname: Hsieh
authors.forename: Y M
authors.initials: YM
authors.lastname: Chen
authors.forename: K D
authors.initials: KD
authors.lastname: Wu
authors.forename: T H
authors.initials: TH
authors.lastname: Chang
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D002216:Captopril / Q000494:pharmacology*; D005260:Female; D005665:Furosemide / Q000494:pharmacology*; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology*; D008297:Male
chemical_list: D005665:Furosemide; D002216:Captopril